Global Aortic Valve Replacement Devices Market to Reach $24.2 Billion by 2030
The global market for Aortic Valve Replacement Devices estimated at US$10.2 Billion in the year 2022, is projected to reach a revised size of US$24.2 Billion by 2030, growing at a CAGR of 11.4% over the analysis period 2022-2030. Minimally Invasive Surgery, one of the segments analyzed in the report, is projected to record 12.4% CAGR and reach US$15.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Open Surgery segment is readjusted to a revised 9.8% CAGR for the next 8-year period.The U.S. Market is Estimated at $2.8 Billion, While China is Forecast to Grow at 16.1% CAGR
The Aortic Valve Replacement Devices market in the U.S. is estimated at US$2.8 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$5.7 Billion by the year 2030 trailing a CAGR of 16.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7% and 9.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.2% CAGR.Select Competitors (Total 42 Featured) -
- Abbott
- BIOTRONIK, Inc.
- Boston Scientific Corporation
- Cryolife, Inc.
- Edwards Lifesciences Corporation
- HLT
- JC Medical, Inc.
- JenaValve Technology, Inc.
- LivaNova PLC. (Sorin Group)
- Medtronic Plc
- St. Jude Medical
- Symetis SA
- Venus Medtech
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott
- BIOTRONIK, Inc.
- Boston Scientific Corporation
- Cryolife, Inc.
- Edwards Lifesciences Corporation
- HLT
- JC Medical, Inc.
- JenaValve Technology, Inc.
- LivaNova PLC. (Sorin Group)
- Medtronic Plc
- St. Jude Medical
- Symetis SA
- Venus Medtech
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 93 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 10.2 Billion |
Forecasted Market Value ( USD | $ 24.2 Billion |
Compound Annual Growth Rate | 11.4% |
Regions Covered | Global |